What is Genesco's earnings per share (EPS)?

Genesco (GCO) reported diluted earnings per share of $1.25 for fiscal year 2026. This represents a 171.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Genesco Financials

GCO

FY2026 annual

Revenue $2.4B +4.8% YoY

Net Income $13.0M +168.4% YoY

EPS (Diluted) $1.25 +171.8% YoY

Free Cash Flow $83.7M +79.0% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2027, ended May 2, 2026 Reported Jun 11, 2026 Currency USD FYE January

Genesco (GCO) reported $2.4B in revenue for fiscal year 2026, up 4.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GCO FY2026 2026-08-15

Genesco’s recovery is chiefly a cash-and-working-capital story: sales returned, but thin operating margins still limit earnings conversion.

Operating cash flow rose from $87.9M in FY2025 to $145.8M in FY2026, while net income returned to a modest profit. That divergence indicates working-capital and noncash effects contributed materially; the recovery was not simply a margin-driven earnings rebound.

Sales increased 4.8% in FY2026, but gross margin compressed to 46.3%. Operating margin still edged up from 0.6% to 0.7%, suggesting expense control or fixed-cost absorption offset weaker gross economics rather than broad pricing-led expansion.

In FY2023, inventory accumulation reached $458.0M while operating cash flow was -$164.9M, showing merchandise buildup can consume cash even when the income statement remains profitable. By FY2026, inventory was $433.9M against $105.4M cash, leaving liquidity more dependent on inventory turnover than on readily available cash.

Financial Health Signals

Financial Health Score 49/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Genesco's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Genesco has an operating margin of 0.7%, meaning the company retains $1 of operating profit per $100 of revenue. This results in a moderate score of 36/100, indicating healthy but not exceptional operating efficiency. This is up from 0.6% the prior year.

Growth

Genesco's revenue grew a modest 4.8% year-over-year to $2.4B. This slow but positive growth earns a score of 40/100.

Leverage

Genesco carries a low D/E ratio of 0.01, meaning only $0.01 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Genesco's current ratio of 1.64 indicates adequate short-term liquidity, earning a score of 46/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Genesco has a free cash flow margin of 3.4%, earning a moderate score of 38/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Genesco's ROE of 2.3% shows moderate profitability relative to equity, earning a score of 36/100. This is up from -3.5% the prior year.

Altman Z-Score Grey Zone

2.54

Genesco scores 2.54, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

7/9

Genesco passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

11.21x

For every $1 of reported earnings, Genesco generates $11.21 in operating cash flow ($145.8M OCF vs $13.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

4.22x

Genesco earns $4.22 in operating income for every $1 of interest expense ($17.3M vs $4.1M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.4B

YoY+4.8%

5Y CAGR+6.4%

10Y CAGR-2.1%

Genesco generated $2.4B in revenue in fiscal year 2026. This represents an increase of 4.8% from the prior year.

EBITDA

$70.6M

YoY+6.4%

10Y CAGR-11.1%

Genesco's EBITDA was $70.6M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 6.4% from the prior year.

Net Income

$13.0M

YoY+168.4%

10Y CAGR-18.0%

Genesco reported $13.0M in net income in fiscal year 2026. This represents an increase of 168.4% from the prior year.

EPS (Diluted)

$1.25

YoY+171.8%

10Y CAGR-11.2%

Genesco earned $1.25 per diluted share (EPS) in fiscal year 2026. This represents an increase of 171.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$83.7M

YoY+79.0%

5Y CAGR-8.9%

10Y CAGR+5.5%

Genesco generated $83.7M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 79.0% from the prior year.

Cash & Debt

$105.4M

YoY+210.0%

5Y CAGR-13.3%

10Y CAGR-2.3%

Genesco held $105.4M in cash against $3.4M in long-term debt as of fiscal year 2026, with $376.3M of liabilities due within a year.

Shares Outstanding

11M

YoY-1.6%

5Y CAGR-6.2%

10Y CAGR-6.5%

Genesco had 11M shares outstanding in fiscal year 2026. This represents a decrease of 1.6% from the prior year.

Dividends Per Share

Not reported for fiscal year 2026.

Margins & Returns

Gross Margin

46.3%

YoY-0.9pp

5Y CAGR+1.2pp

10Y CAGR-1.5pp

Genesco's gross margin was 46.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 0.9 percentage points from the prior year.

Operating Margin

0.7%

YoY+0.1pp

5Y CAGR+6.7pp

10Y CAGR-4.3pp

Genesco's operating margin was 0.7% in fiscal year 2026, reflecting core business profitability. This is up 0.1 percentage points from the prior year.

Net Margin

0.5%

YoY+1.4pp

5Y CAGR+3.7pp

10Y CAGR-2.6pp

Genesco's net profit margin was 0.5% in fiscal year 2026, showing the share of revenue converted to profit. This is up 1.4 percentage points from the prior year.

Return on Equity

2.3%

YoY+5.8pp

5Y CAGR+12.3pp

10Y CAGR-7.6pp

Genesco's ROE was 2.3% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 5.8 percentage points from the prior year.

Capital Allocation

Share Buybacks

$12.6M

YoY+28.4%

10Y CAGR-21.5%

Genesco spent $12.6M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 28.4% from the prior year.

Capital Expenditures

$62.1M

YoY+50.9%

5Y CAGR+20.8%

10Y CAGR-4.7%

Genesco invested $62.1M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 50.9% from the prior year.

R&D Spending

Not reported for fiscal year 2026.

GCO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

GCO quarterly income statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	$2.4B+4.8%	$2.3B0.0%	$2.3B-2.5%	$2.4B-1.5%	$2.4B+35.6%	$1.8B-18.7%	$2.2B+0.4%	$2.2B+2.9%	$2.1B+5.3%	$2.0B-33.1%	$3.0B+5.7%	$2.9B+8.9%	$2.6B+0.7%	$2.6B+13.7%	$2.3B
Cost of Revenue	$1.3B+6.6%	$1.2B+0.2%	$1.2B-1.8%	$1.2B+0.6%	$1.2B+26.4%	$982.1M-13.4%	$1.1B-0.7%	$1.1B+2.3%	$1.1B+6.8%	$1.0B-33.8%	$1.6B+8.2%	$1.5B+10.1%	$1.3B+1.5%	$1.3B+14.2%	$1.1B
Gross Profit	$1.1B+2.7%	$1.1B-0.2%	$1.1B-3.3%	$1.1B-3.8%	$1.2B+46.8%	$804.5M-24.3%	$1.1B+1.5%	$1.0B+3.5%	$1.0B-28.7%	$1.4B-1.8%	$1.4B+3.1%	$1.4B+7.8%	$1.3B0.0%	$1.3B+13.1%	$1.1B
SG&A Expenses	$1.1B+2.0%	$1.1B-0.2%	$1.1B+3.8%	$1.0B+0.8%	$1.0B+27.0%	$813.8M-15.8%	$966.4M+0.5%	$962.1M+3.5%	$929.2M+6.1%	$876.2M-31.8%	$1.3B+4.3%	$1.2B+8.5%	$1.1B+2.0%	$1.1B+13.0%	$984.2M
Operating Income	$17.3M+24.3%	$13.9M+203.5%	-$13.5M-114.4%	$93.2M-40.1%	$155.6M+245.1%	-$107.2M-228.7%	$83.3M+1.8%	$81.8M+10.0%	$74.4M-31.0%	$107.8M-28.7%	$151.3M-9.6%	$167.3M+2.3%	$163.4M-3.8%	$169.9M+5.2%	$161.5M
Interest Expense	-$4.1M+3.6%	-$4.3M-154.6%	$7.8M+166.3%	$2.9M+19.3%	$2.4M-51.9%	$5.1M+298.3%	$1.3M-68.9%	$4.1M-24.1%	$5.4M+2.4%	$5.3M+19.9%	$4.4M+32.3%	$3.3M-28.1%	$4.6M-9.5%	$5.1M-0.6%	$5.2M
Income Tax	-$685K-102.4%	$28.8M+1454.5%	$1.9M-89.6%	$17.8M-53.1%	$38.0M+168.4%	-$55.6M-369.1%	$20.7M-23.5%	$27.0M-16.3%	$32.3M-19.0%	$39.9M-29.0%	$56.2M-2.5%	$57.6M-12.5%	$65.9M+26.8%	$51.9M-17.5%	$62.9M
Net Income	$13.0M+168.4%	-$19.0M-11.8%	-$17.0M-123.6%	$71.9M-37.4%	$114.8M+303.5%	-$56.4M-191.9%	$61.4M+218.2%	-$51.9M+53.6%	-$111.8M-214.8%	$97.4M+3.0%	$94.6M-3.2%	$97.7M+5.5%	$92.7M-17.6%	$112.4M+21.6%	$92.4M
EPS (Diluted)	$1.25+171.8%	-$1.74-16.0%	-$1.50-126.5%	$5.66-28.5%	$7.92+299.5%	-$3.97-201.3%	$3.92+247.4%	-$2.66+54.1%	-$5.80-220.1%	$4.83+17.5%	$4.11-0.2%	$4.12+5.1%	$3.92-16.2%	$4.68+23.5%	$3.79

Metric	Q2'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Revenue	$487.0M-21.0%	$616.2M+12.9%	$546.0M+15.2%	$474.0M-35.0%	$729.6M+22.3%	$596.3M+13.5%	$525.2M+14.8%	$457.6M
Cost of Revenue	$258.1M-21.2%	$327.6M+10.7%	$296.0M+17.1%	$252.8M-34.3%	$384.8M+23.7%	$311.1M+11.3%	$279.5M+15.8%	$241.3M
Gross Profit	$228.9M-20.7%	$288.6M+15.5%	$249.9M+13.0%	$221.2M-35.8%	$344.7M+20.9%	$285.3M+16.1%	$245.6M+13.6%	$216.3M
SG&A Expenses	$254.4M-7.7%	$275.7M+4.3%	$264.3M+6.1%	$249.0M-17.1%	$300.6M+9.3%	$274.9M+7.8%	$255.1M+2.9%	$247.8M
Operating Income	-$15.4M-279.3%	$8.6M+159.4%	-$14.4M+48.7%	-$28.1M-166.8%	$42.1M+312.7%	$10.2M+199.4%	-$10.3M+68.0%	-$32.1M
Interest Expense	-$265K+70.0%	-$884K+39.4%	-$1.5M-9.0%	-$1.3M+75.5%	-$5.5M-550.9%	$1.2M-9.8%	$1.3M+51.1%	$890K
Income Tax	-$1.1M-150.6%	$2.1M-12.0%	$2.4M+128.5%	-$8.5M-174.9%	$11.3M-59.3%	$27.8M+1663.0%	-$1.8M+79.9%	-$8.8M
Net Income	-$14.8M-376.6%	$5.4M+129.0%	-$18.5M+13.0%	-$21.2M-168.1%	$31.2M+264.5%	-$18.9M-89.5%	-$10.0M+59.0%	-$24.3M
EPS (Diluted)	-$1.42-384.0%	$0.50+127.9%	-$1.79+11.4%	-$2.02-163.9%	$3.16+279.5%	-$1.76-93.4%	-$0.91+59.2%	-$2.23

Not reported in any period shown, so not listed: R&D Expenses.

GCO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

GCO quarterly balance sheet

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Total Assets	$1.4B+4.3%	$1.3B+0.4%	$1.3B-8.7%	$1.5B-6.8%	$1.6B-1.6%	$1.6B-5.5%	$1.7B+42.3%	$1.2B-10.2%	$1.3B-8.7%	$1.4B-6.5%	$1.5B-2.6%	$1.6B+10.0%	$1.4B+8.5%	$1.3B+7.8%	$1.2B
Current Assets	$618.5M+1.6%	$608.8M+20.0%	$507.4M-11.4%	$572.7M-19.3%	$709.8M+6.3%	$667.6M+31.4%	$508.2M-30.5%	$731.0M+5.5%	$693.1M-3.3%	$717.0M-10.4%	$800.1M-5.6%	$847.7M+12.0%	$756.9M+10.9%	$682.3M+14.6%	$595.3M
Cash & Equivalents	$105.4M+210.0%	$34.0M-3.3%	$35.2M-26.7%	$48.0M-85.0%	$320.5M+49.0%	$215.1M+164.2%	$81.4M-51.4%	$167.4M+319.0%	$39.9M-17.3%	$48.3M-63.8%	$133.3M+18.1%	$112.9M+89.9%	$59.4M-0.6%	$59.8M+11.2%	$53.8M
Inventory	$433.9M+2.0%	$425.2M+12.2%	$379.0M-17.3%	$458.0M+64.6%	$278.2M-4.4%	$291.0M-20.3%	$365.3M-0.4%	$366.7M-5.6%	$388.4M-31.1%	$563.7M+6.4%	$529.8M-11.4%	$598.1M+5.4%	$567.3M+12.3%	$505.3M+16.1%	$435.1M
Accounts Receivable	$39.8M-18.5%	$48.9M-8.9%	$53.6M+31.4%	$40.8M+3.3%	$39.5M+25.8%	$31.4M+7.6%	$29.2M-77.9%	$132.4M+293.9%	$33.6M-22.8%	$43.5M-7.9%	$47.3M-14.5%	$55.3M+5.0%	$52.6M+9.2%	$48.2M+10.3%	$43.7M
Goodwill	$9.5M+6.7%	$8.9M-7.3%	$9.6M-74.9%	$38.1M-1.1%	$38.6M0.0%	$38.5M-68.4%	$122.2M+31.3%	$93.1M-7.2%	$100.3M-63.0%	$271.2M-3.6%	$281.4M-5.2%	$296.9M+3.0%	$288.1M+5.2%	$273.8M+5.4%	$259.8M
Total Liabilities	$825.9M+4.7%	$788.6M+3.9%	$758.7M-10.7%	$849.5M-11.5%	$959.6M-6.0%	$1.0B-3.8%	$1.1B+139.2%	$443.5M-8.5%	$484.6M-6.5%	$518.5M-11.3%	$584.4M0.0%	$584.3M+12.1%	$521.2M+3.8%	$502.3M+0.3%	$500.8M
Current Liabilities	$376.3M-0.9%	$379.8M+18.9%	$319.5M-11.4%	$360.8M-16.4%	$431.7M+7.1%	$402.9M+11.3%	$361.9M+31.0%	$276.2M+8.3%	$255.1M-17.6%	$309.4M-4.4%	$323.6M-20.3%	$405.9M+32.8%	$305.6M+11.0%	$275.2M-9.3%	$303.3M
Long-Term Debt	$3.4M	$0-100.0%	$34.7M-22.7%	$44.9M+186.1%	$15.7M-52.5%	$33.0M+129.2%	$14.4M-74.6%	$56.8M-34.5%	$86.6M+17.5%	$73.7M-24.4%	$97.6M+509.8%	$16.0M-40.6%	$26.9M-40.1%	$45.0M+41.0%	$31.9M
Total Equity	$567.0M+3.7%	$547.0M-4.2%	$571.2M-5.9%	$607.0M+0.7%	$602.5M+6.3%	$566.8M-8.5%	$619.3M-16.0%	$737.6M-11.2%	$830.7M-9.8%	$921.1M-3.6%	$955.2M-4.2%	$996.8M+8.8%	$916.2M+11.5%	$821.9M+13.1%	$726.7M
Retained Earnings	$265.8M0.0%	$265.9M-10.4%	$296.8M-14.4%	$346.9M-1.0%	$350.2M+9.1%	$320.9M-15.2%	$378.6M-25.6%	$508.6M-15.8%	$603.9M-17.4%	$731.1M-4.8%	$768.2M-6.4%	$820.6M+11.7%	$734.5M+9.8%	$669.2M+11.8%	$598.4M

Metric	Q2'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Total Assets	$1.4B-6.0%	$1.5B+3.5%	$1.4B+1.2%	$1.4B+5.2%	$1.3B-7.0%	$1.4B+3.7%	$1.4B+5.8%	$1.3B
Current Assets	$595.8M-13.5%	$689.1M+6.7%	$645.9M+2.0%	$633.3M+4.0%	$608.8M-7.7%	$659.7M+8.7%	$606.7M+19.4%	$508.0M
Cash & Equivalents	$27.1M+0.3%	$27.0M-34.0%	$41.0M+88.5%	$21.7M-36.0%	$34.0M+1.3%	$33.6M-26.8%	$45.9M+138.2%	$19.2M
Inventory	$476.9M-14.6%	$558.1M+11.4%	$501.0M+11.1%	$450.8M+6.0%	$425.2M-18.7%	$523.2M+16.2%	$450.2M+14.6%	$392.7M
Accounts Receivable	$47.7M-14.6%	$55.8M+2.8%	$54.3M+2.9%	$52.8M+8.1%	$48.9M-6.7%	$52.4M-8.9%	$57.5M+14.7%	$50.1M
Goodwill	$9.5M+3.3%	$9.2M0.0%	$9.2M-1.5%	$9.3M+5.1%	$8.9M-4.0%	$9.2M-0.6%	$9.3M-1.4%	$9.4M
Total Liabilities	$831.6M-13.2%	$958.3M+4.7%	$915.6M+3.8%	$882.4M+11.9%	$788.6M-14.2%	$918.6M+7.9%	$851.1M+12.1%	$759.0M
Current Liabilities	$324.9M-25.5%	$436.0M+5.2%	$414.4M+25.2%	$330.9M-12.9%	$379.8M-10.0%	$422.1M+6.7%	$395.7M+28.4%	$308.2M
Long-Term Debt	$45.3M-35.0%	$69.8M+21.0%	$57.7M-49.3%	$113.7M	N/A	$100.1M+28.6%	$77.8M+30.9%	$59.4M
Total Equity	$552.4M+7.5%	$513.8M+1.5%	$506.4M-3.0%	$522.2M-4.5%	$547.0M+5.8%	$516.9M-3.0%	$532.6M-2.9%	$548.5M
Retained Earnings	$248.9M+14.0%	$218.3M+2.5%	$213.0M-8.2%	$232.0M-12.7%	$265.9M+14.6%	$232.0M-7.7%	$251.4M-7.5%	$271.6M

GCO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

GCO quarterly cash flow statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Operating Cash Flow	$145.8M+65.9%	$87.9M-7.3%	$94.8M+157.5%	-$164.9M-168.7%	$239.9M+52.1%	$157.7M+34.6%	$117.2M-50.6%	$237.1M+44.1%	$164.6M-0.4%	$165.2M+10.4%	$149.7M-21.1%	$189.8M+35.5%	$140.0M+13.6%	$123.2M-15.0%	$145.0M
Capital Expenditures	$62.1M+50.9%	$41.1M-31.8%	$60.3M+0.6%	$59.9M+11.2%	$53.9M+123.4%	$24.1M-18.9%	$29.8M-48.0%	$57.2M-55.2%	$127.9M+36.1%	$94.0M-6.6%	$100.7M-2.4%	$103.1M+4.7%	$98.5M+37.2%	$71.7M+45.1%	$49.5M
Free Cash Flow	$83.7M+79.0%	$46.8M+35.5%	$34.5M+115.3%	-$224.8M-220.9%	$186.0M+39.2%	$133.6M+52.9%	$87.4M-51.4%	$179.9M+389.7%	$36.7M-48.5%	$71.3M+45.4%	$49.0M-43.4%	$86.7M+108.6%	$41.5M-19.3%	$51.5M-46.1%	$95.5M
Investing Cash Flow	-$62.1M-50.9%	-$41.1M+31.4%	-$60.0M-0.1%	-$59.9M-76.8%	-$33.9M-41.1%	-$24.0M-145.1%	$53.3M+194.3%	-$56.5M+55.7%	-$127.6M-79.9%	-$70.9M+6.4%	-$75.8M+44.9%	-$137.7M-23.0%	-$111.9M-17.3%	-$95.5M+33.0%	-$142.4M
Financing Cash Flow	-$13.3M+71.7%	-$47.0M+1.2%	-$47.6M-4.5%	-$45.5M+55.0%	-$101.2M-3097.5%	-$3.2M+98.8%	-$256.5M-386.2%	-$52.8M-11.3%	-$47.4M+73.4%	-$178.2M-242.0%	-$52.1M-3496.5%	-$1.4M+95.2%	-$29.9M-37.2%	-$21.8M-448.1%	-$4.0M
Share Buybacks	$12.6M+28.4%	$9.8M-69.4%	$32.0M-58.7%	$77.5M-0.8%	$78.1M	$0-100.0%	$190.4M+323.7%	$44.9M+178.0%	$16.2M-88.5%	$140.5M-1.1%	$142.1M+2964.9%	$4.6M-77.6%	$20.7M-45.1%	$37.6M	$0

Metric	Q2'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Operating Cash Flow	-$102.8M-696.4%	-$12.9M-114.9%	$86.3M+185.5%	-$101.0M-186.4%	$117.0M+606.9%	-$23.1M-183.3%	$27.7M+182.1%	-$33.7M
Capital Expenditures	$15.4M-17.1%	$18.6M+26.7%	$14.7M-22.3%	$18.9M+37.6%	$13.7M+4.7%	$13.1M+66.2%	$7.9M+23.8%	$6.4M
Free Cash Flow	-$118.2M-275.1%	-$31.5M-144.0%	$71.7M+159.8%	-$119.9M-216.1%	$103.3M+385.2%	-$36.2M-282.7%	$19.8M+149.4%	-$40.1M
Investing Cash Flow	-$15.4M+17.1%	-$18.6M-26.7%	-$14.7M+22.3%	-$18.9M-37.6%	-$13.7M-4.7%	-$13.1M-66.2%	-$7.9M-23.8%	-$6.4M
Financing Cash Flow	$40.0M+128.0%	$17.5M+133.5%	-$52.4M-148.9%	$107.3M+205.7%	-$101.5M-529.9%	$23.6M+253.6%	$6.7M-72.4%	$24.2M
Share Buybacks	$0	$0	$0-100.0%	$12.6M	$0-100.0%	$440K-95.3%	$9.3M	$0

Not reported in any period shown, so not listed: Dividends Paid.

GCO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

GCO quarterly financial ratios

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Gross Margin	46.3%-0.9pp	47.2%-0.1pp	47.3%-0.4pp	47.6%-1.1pp	48.8%+3.7pp	45.0%-3.4pp	48.4%+0.6pp	47.8%+0.3pp	47.5%-22.6pp	70.2%+22.4pp	47.8%-1.2pp	49.0%-0.5pp	49.5%-0.3pp	49.8%-0.3pp	50.1%
Operating Margin	0.7%+0.1pp	0.6%+1.2pp	-0.6%-4.5pp	3.9%-2.5pp	6.4%+12.4pp	-6.0%-9.8pp	3.8%+0.1pp	3.7%+0.2pp	3.5%-1.8pp	5.3%+0.3pp	5.0%-0.9pp	5.9%-0.4pp	6.2%-0.3pp	6.5%-0.5pp	7.0%
Net Margin	0.5%+1.4pp	-0.8%-0.1pp	-0.7%-3.8pp	3.0%-1.7pp	4.7%+7.9pp	-3.2%-6.0pp	2.8%+5.2pp	-2.4%+2.9pp	-5.3%-10.1pp	4.8%+1.7pp	3.1%-0.3pp	3.4%-0.1pp	3.5%-0.8pp	4.3%+0.3pp	4.0%
Return on Equity	2.3%+5.8pp	-3.5%-0.5pp	-3.0%-14.8pp	11.8%-7.2pp	19.1%+29.0pp	-10.0%-19.9pp	9.9%+16.9pp	-7.0%+6.4pp	-13.5%-24.0pp	10.6%+0.7pp	9.9%+0.1pp	9.8%-0.3pp	10.1%-3.6pp	13.7%+1.0pp	12.7%
Return on Assets	0.9%+2.4pp	-1.4%-0.1pp	-1.3%-6.2pp	4.9%-2.4pp	7.3%+10.9pp	-3.5%-7.2pp	3.6%+8.0pp	-4.4%+4.1pp	-8.5%-15.3pp	6.8%+0.6pp	6.1%0.0pp	6.2%-0.3pp	6.4%-2.0pp	8.5%+1.0pp	7.5%
Current Ratio	1.640.0x	1.600.0x	1.590.0x	1.59-0.1x	1.640.0x	1.66+0.3x	1.40-1.2x	2.65-0.1x	2.72+0.4x	2.32-0.2x	2.47+0.4x	2.09-0.4x	2.480.0x	2.48+0.5x	1.96
Debt-to-Equity	0.010.0x	0.00-0.1x	0.060.0x	0.070.0x	0.030.0x	0.060.0x	0.02-0.1x	0.080.0x	0.100.0x	0.080.0x	0.10+0.1x	0.020.0x	0.030.0x	0.050.0x	0.04
FCF Margin	3.4%+1.4pp	2.0%+0.5pp	1.5%+10.9pp	-9.4%-17.1pp	7.7%+0.2pp	7.5%+3.5pp	4.0%-4.2pp	8.2%+6.5pp	1.7%-1.8pp	3.5%+1.9pp	1.6%-1.4pp	3.0%+1.4pp	1.6%-0.4pp	2.0%-2.2pp	4.2%

Metric	Q2'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Gross Margin	47.0%+0.2pp	46.8%+1.1pp	45.8%-0.9pp	46.7%-0.6pp	47.3%-0.6pp	47.8%+1.1pp	46.8%-0.5pp	47.3%
Operating Margin	-3.2%-4.5pp	1.4%+4.0pp	-2.6%+3.3pp	-5.9%-11.7pp	5.8%+4.1pp	1.7%+3.7pp	-2.0%+5.1pp	-7.0%
Net Margin	-3.0%-3.9pp	0.9%+4.3pp	-3.4%+1.1pp	-4.5%-8.8pp	4.3%+7.4pp	-3.2%-1.3pp	-1.9%+3.4pp	-5.3%
Return on Equity	-2.7%-3.7pp	1.0%+4.7pp	-3.6%+0.4pp	-4.1%-9.8pp	5.7%+9.4pp	-3.7%-1.8pp	-1.9%+2.6pp	-4.4%
Return on Assets	-1.1%-1.4pp	0.4%+1.7pp	-1.3%+0.2pp	-1.5%-3.8pp	2.3%+3.7pp	-1.3%-0.6pp	-0.7%+1.1pp	-1.9%
Current Ratio	1.83+0.3x	1.580.0x	1.56-0.4x	1.91+0.3x	1.600.0x	1.560.0x	1.53-0.1x	1.65
Debt-to-Equity	0.08-0.1x	0.140.0x	0.11-0.1x	0.22-1.2x	1.44+1.2x	0.190.0x	0.150.0x	0.11
FCF Margin	-24.3%-19.2pp	-5.1%-18.2pp	13.1%+38.4pp	-25.3%-39.4pp	14.1%+20.2pp	-6.1%-9.8pp	3.8%+12.5pp	-8.8%

Similar Companies

$311.3M

$438.3M

$368.0M

$473.2M

$876.7M

Where Genesco Ranks

Frequently Asked Questions

What is Genesco's annual revenue?

Genesco (GCO) reported $2.4B in total revenue for fiscal year 2026. This represents a 4.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Genesco's revenue growing?

Genesco (GCO) revenue grew by 4.8% year-over-year, from $2.3B to $2.4B in fiscal year 2026.

Is Genesco profitable?

Yes, Genesco (GCO) reported a net income of $13.0M in fiscal year 2026, with a net profit margin of 0.5%.

What is Genesco's EBITDA?

Genesco (GCO) had EBITDA of $70.6M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Genesco have?

As of fiscal year 2026, Genesco (GCO) had $105.4M in cash and equivalents against $3.4M in long-term debt.

What is Genesco's gross margin?

Genesco (GCO) had a gross margin of 46.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Genesco's operating margin?

Genesco (GCO) had an operating margin of 0.7% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Genesco's net profit margin?

Genesco (GCO) had a net profit margin of 0.5% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is Genesco's return on equity (ROE)?

Genesco (GCO) has a return on equity of 2.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Genesco's free cash flow?

Genesco (GCO) generated $83.7M in free cash flow during fiscal year 2026. This represents a 79.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Genesco's operating cash flow?

Genesco (GCO) generated $145.8M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Genesco's total assets?

Genesco (GCO) had $1.4B in total assets as of fiscal year 2026, including both current and long-term assets.

What are Genesco's capital expenditures?

Genesco (GCO) invested $62.1M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Does Genesco buy back shares?

Yes, Genesco (GCO) spent $12.6M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does Genesco have outstanding?

Genesco (GCO) had 11M shares outstanding as of fiscal year 2026.

What is Genesco's current ratio?

Genesco (GCO) had a current ratio of 1.64 as of fiscal year 2026, which is generally considered healthy.

What is Genesco's debt-to-equity ratio?

Genesco (GCO) had a debt-to-equity ratio of 0.01 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Genesco's return on assets (ROA)?

Genesco (GCO) had a return on assets of 0.9% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Genesco's Altman Z-Score?

Genesco (GCO) has an Altman Z-Score of 2.54, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Genesco's Piotroski F-Score?

Genesco (GCO) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Genesco's earnings high quality?

Genesco (GCO) has an earnings quality ratio of 11.21x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Genesco cover its interest payments?

Genesco (GCO) has an interest coverage ratio of 4.22x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Genesco?

Genesco (GCO) scores 49 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.